Target intelligence / Profile preview

Fluoride–enamel hydroxyapatite interface

Molecular classification
Biomineral, Inorganic crystal interface, Other
01

Overview

The fluoride–enamel hydroxyapatite interface is the physicochemical site where fluoride ions interact with hydroxyapatite, the primary mineral component of human tooth enamel (StatPearls, 2023). This interface is a critical therapeutic target in preventative dentistry because the incorporation of fluoride into the crystal lattice results in the formation of fluorapatite, which is significantly more resistant to acid dissolution than pure hydroxyapatite (NIH, 2023). By lowering the critical pH at which enamel begins to demineralize, fluoride effectively protects the tooth structure from decay caused by plaque-derived acids (Buzalaf et al., 2011). Beyond structural reinforcement, the interface facilitates the remineralization of early-stage carious lesions by acting as a scaffold for calcium and phosphate deposition from saliva (CDC, 2021). Fluoride also exerts an antimicrobial effect at this interface by inhibiting bacterial enzymes like enolase, thereby reducing the acid production of oral pathogens (Journal of Dental Research, 2011). Consequently, targeting this interface with topical fluoride treatments is the primary global strategy for managing dental caries and maintaining oral health.

Other names
Fluorapatite interfaceFluoridated hydroxyapatite surfaceEnamel mineral interfaceHydroxyapatite-fluoride boundary
02

Mechanism of action

Fluoride ions interact with the hydroxyapatite crystal lattice [Ca10(PO4)6(OH)2] by substituting for hydroxyl groups to form fluorapatite [Ca10(PO4)6F2], which is more resistant to acid dissolution (StatPearls, 2023). It also lowers the solubility product of the enamel surface, promotes the remineralization of incipient lesions by attracting calcium and phosphate ions, and inhibits bacterial enolase enzymes to reduce acid production (Buzalaf et al., 2011).

03

Biological functions

BiomineralizationAcid resistanceIon exchangeRemineralizationStructural integrity
04

Disease associations

Dental cariesDental erosionEnamel hypomineralizationDentinal hypersensitivity
05

Safety considerations

Dental fluorosis (during tooth development)Skeletal fluorosis (chronic systemic overexposure)Acute toxicity/gastric irritation (if ingested in high doses)Neurotoxicity (debated at high systemic levels)
06

Interacting drugs

Sodium fluoride

4 more in the full profile.

07

Biomarkers

Enamel fluoride uptake (EFU)Surface microhardness (SMH)Acid solubility reductionWhite spot lesion (WSL) volume

Beyond the preview

Go deeper on Fluoride–enamel hydroxyapatite interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluoride–enamel hydroxyapatite interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call